Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Ann Thorac Surg. 2014 Apr;97(4):1199-206. doi: 10.1016/j.athoracsur.2013.11.064. Epub 2014 Feb 6.
Data from small selected patient populations suggest that the preoperative plasma concentration of fibrinogen influences postoperative blood loss and red blood cell transfusion after cardiac operations, but there are also conflicting reports. We assessed the importance of preoperative fibrinogen concentration for excessive bleeding and red cell blood transfusion in a large cohort of mixed cardiac surgical patients.
We included 1,954 cardiac surgical patients in a prospective observational study. The fibrinogen plasma concentration was measured on the day before the operation. Blood loss (mediastinal drain volume) during the first 12 postoperative hours and red blood cell transfusion during the hospital stay were registered and related to fibrinogen concentration with logistic regression models. Excessive bleeding was defined as postoperative blood loss exceeding 1,000 mL/12 hours.
The preoperative fibrinogen concentration was inversely proportional to the prevalence of excessive bleeding in univariate testing (odds ratio [OR], 0.75; 95% confidence interval [CI], 0.64 to 0.89 per g/L; p=0.001) and also in a multiple model adjusted for age, sex, body mass index, renal function, acuteness of the operation, cardiopulmonary bypass time, clopidogrel use less than 5 days before the operation, and type of operation (OR for fibrinogen, 0.82; 95% CI, 0.69 to 0.97; p=0.024). In contrast, the prevalence of red cell blood transfusion increased with increasing fibrinogen levels in univariate testing (OR, 1.36; 95% CI, 1.24 to 1.49; p<0.001) but not in a multiple model (OR, 1.10; 95% CI, 0.89 to 1.28; p=0.49).
Preoperative plasma concentration of fibrinogen is independently associated with excessive bleeding after cardiac operations but not with red blood cell transfusion.
来自小部分患者人群的数据表明,术前纤维蛋白原浓度会影响心脏手术后的术后失血量和红细胞输血,但也有相互矛盾的报告。我们评估了术前纤维蛋白原浓度对大量混合心脏手术患者中过度出血和红细胞输血的重要性。
我们纳入了一项前瞻性观察性研究中的 1954 名心脏手术患者。在手术前一天测量纤维蛋白原的血浆浓度。记录术后 12 小时内的失血量(纵隔引流体积)和住院期间的红细胞输血,并通过逻辑回归模型与纤维蛋白原浓度相关联。过度出血定义为术后失血量超过 1000 毫升/12 小时。
在单变量检验中,术前纤维蛋白原浓度与过度出血的患病率呈反比(比值比[OR],0.75;95%置信区间[CI],0.64 至 0.89/克/升;p=0.001),在调整年龄、性别、体重指数、肾功能、手术紧迫性、体外循环时间、术前 5 天内使用氯吡格雷、手术类型等因素的多模型中也是如此(纤维蛋白原的 OR,0.82;95%CI,0.69 至 0.97;p=0.024)。相反,在单变量检验中,红细胞输血的患病率随着纤维蛋白原水平的升高而升高(OR,1.36;95%CI,1.24 至 1.49;p<0.001),但在多模型中并非如此(OR,1.10;95%CI,0.89 至 1.28;p=0.49)。
术前纤维蛋白原血浆浓度与心脏手术后的过度出血独立相关,但与红细胞输血无关。